Discover and read the best of Twitter Threads about #UnregulatedMonopoly
Most recents (1)
Medicare Part D spends 60% of its money on 250 drugs that have only one manufacturer and no generic or biosimilar competitors. #UnregulatedMonopoly
13% on 2,208 other drugs with only one manufacturer
27% on 1,078 drugs with more than one manufacturer.
kff.org/medicare/issue…
13% on 2,208 other drugs with only one manufacturer
27% on 1,078 drugs with more than one manufacturer.
kff.org/medicare/issue…
Not all drugs with only one manufacturer are a monopoly. That's why some of single source drugs are lower priced. If an alternative drug is available from another manufacturer, there's competition; many equivalent drugs, especially generic equivalents, means real competition.
On the other hand, if a new cancer drug works for only a few months or years, and then stops working - the case with most cancer medicines - then even if there are multiple meds EACH drug remains a monopoly. Because we want to try each drug and prolong life the most we can.
